Table 1.
Age (yr) | Sex | Diagnosis | History of Smoking | Supplemental Oxygen Use before Transplant | Sample ID |
---|---|---|---|---|---|
66* | M | IPF | Yes | Yes | IPF 1 |
60* | M | IPF | No | Yes | IPF 2 |
68* | M | IPF | Yes | Yes | IPF 3 |
72* | F | IPF | No | Yes | IPF 4 |
55* | F | Hypersensitivity pneumonitis | No | Yes | HP |
39* | F | Systemic sclerosis–associated ILD | No | Yes | SSc-ILD 1 |
53* | F | Systemic sclerosis–associated ILD | No | Yes | SSc-ILD 2 |
37* | F | Myositis-associated ILD | No | Yes | PM-ILD |
71† | F | IPF | Yes | No | Cryobiopsy |
42‡ | M | Systemic sclerosis–associated ILD | No | Yes | NA |
65‡ | M | IPF | No | Yes | NA |
52‡ | M | Systemic sclerosis–associated ILD | Yes | Yes | NA |
52‡ | F | Systemic sclerosis–associated ILD | No | Yes | NA |
55‡ | F | Myositis-associated ILD | No | Yes | NA |
56‡ | F | Hypersensitivity pneumonitis | No | Yes | NA |
60‡ | M | Myositis-associated ILD | Yes | Yes | NA |
67‡ | M | IPF | Yes | No | NA |
Definition of abbreviations: HP = hypersensitivity pneumonitis; ILD = interstitial lung disease; IPF = idiopathic pulmonary fibrosis; NA = not applicable; PM = polymyositis; SSc = systemic sclerosis.
Representative histopathology with pathologist interpretation is found in Figure E1A.
Transplant recipients with pulmonary fibrosis included in single-cell RNA-Seq analysis.
Patient with IPF undergoing cryobiopsy included in single-cell RNA-Seq analysis.
Transplant recipients with pulmonary fibrosis included in bulk RNA-Seq analysis.